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Abstract 38 
Studies of spliceosomal interactions are challenging due to their dynamic nature. Here 39 
we employed spliceosome iCLIP, which immunoprecipitates SmB along with snRNPs 40 
and auxiliary RNA binding proteins (RBPs), to map spliceosome engagement with pre-41 
mRNAs in human cell lines. This revealed seven peaks of spliceosomal crosslinking 42 
around branchpoints (BPs) and splice sites. We identified RBPs that crosslink to each 43 
peak, including known and candidate splicing factors. Moreover, we detected use of over 44 
40,000 BPs with strong sequence consensus and structural accessibility, which align 45 
well to nearby crosslinking peaks. We show how the position and strength of BPs affect 46 
the crosslinking patterns of spliceosomal factors, which bind more efficiently upstream 47 
of strong or proximally located BPs, and downstream of weak or distally located BPs. 48 
These insights exemplify spliceosome iCLIP as a broadly applicable method for 49 
transcriptomic studies of splicing mechanisms. 50 
51 
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Introduction 52 
Splicing is a multi-step process in which small nuclear ribonucleoprotein particles 53 
(snRNPs) and associated splicing factors bind at specific positions around intron 54 
boundaries in order to assemble an active spliceosome through a series of remodeling 55 
steps. The splicing reactions are coordinated by dynamic pairings between different 56 
snRNAs, between snRNAs and pre-mRNA, and by protein-RNA contacts1. Spliceosome 57 
assembly begins with ATP-independent binding of U1 snRNP at the 5' splice site (ss), 58 
and of U2 small nuclear RNA auxiliary factors 1 and 2 (U2AF1 and U2AF2, also known as 59 
U2AF35 and U2AF65) to the 3'ss. ATP-dependent remodeling then leads to the 60 
formation of complex A in which U2 snRNP contacts the branchpoint (BP), stabilized 61 
through interactions with the U2AF and U2 snRNP splicing factor 3 (SF3a and SF3b) 62 
complex. Next, U4/U6 and U5 snRNPs are recruited to form complex B. The actions of 63 
many RNA helicases and pre-mRNA processing factor 8 (PRPF8) then facilitate 64 
rearrangements of snRNP interactions and establishment of the catalytically competent 65 
Bact and C complexes. These catalyze the two trans-esterification reactions leading to 66 
lariat formation, intron removal and exon ligation2. 67 
Transcriptome-wide studies of splicing reactions are valuable to unravel the multi-68 
component and dynamic assembly of the spliceosome on the pre-mRNA substrate3-5. 69 
Accordingly, “spliceosome profiling” has been developed through affinity purification of 70 
the tagged U2·U5·U6·NTC complex from Schizosaccharomyces pombe to monitor its 71 
interactions using a RNA footprinting-based strategy3,4. However, it is unclear if this 72 
method can be applied to mammalian cells which might be more sensitive to 73 
introduction of affinity tags into splicing factors. Furthermore, no method has 74 
simultaneously monitored the full complexity of the interactions of diverse RBPs on pre-75 
mRNAs from the earliest to the latest stages of spliceosomal assembly. 76 
Here, we have adapted the individual nucleotide resolution UV crosslinking and 77 
immunoprecipitation (iCLIP) method6 to develop spliceosome iCLIP. This approach 78 
identifies crosslinks of endogenous, untagged spliceosomal factors on pre-mRNAs at 79 
nucleotide resolution. In a previous study, we demonstrated validity of this approach by 80 
showing how PRPF8 remodels spliceosomal contacts at 5'ss5. Here, we comprehensively 81 
characterize spliceosome iCLIP and show that it simultaneously maps the crosslink 82 
profiles of core and accessory spliceosomal factors that are known to participate across 83 
the diverse stages of the splicing cycle. Due to iCLIP’s nucleotide precision, we 84 
distinguished 7 binding peaks corresponding to distinct RBPs that differ in their 85 
requirement for ATP or the factor PRPF8. Spliceosome iCLIP also purifies intron lariats 86 
and identified 132,287 candidate BP positions. Compared to BPs identified in previous 87 
RNA-seq studies7-9, those identified by spliceosome iCLIP contain more canonical 88 
sequence and structural features. We further examined the binding profiles of 89 
spliceosomal RBPs around the BPs. This demonstrates that assembly of SF3 and 90 
associated spliceosomal complexes tends to be determined by a primary BP in most 91 
introns, even though alternative BPs are detected by lariat-derived reads in RNA-seq. 92 
Moreover, we identify complementary roles of U2AF and SF3 complexes in BP 93 
definition. Taken together, these findings demonstrate the value of spliceosome iCLIP 94 
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for transcriptome-wide studies of BP definition and spliceosomal interactions with pre-95 
mRNAs. 96 
Results 97 
Spliceosome iCLIP identifies interactions between splicing factors, snRNAs and 98 
pre-mRNAs 99 
SmB/B' proteins are part of the highly stable Sm core common to all spliceosomal 100 
snRNPs except U61. In order to adapt iCLIP for the study of a multi-component machine 101 
like the spliceosome, we immunopurified endogenous SmB/B' proteins10 using a range 102 
of conditions with differing stringency of detergents and salt concentrations for the lysis 103 
and washing steps (Supplementary Table 1, Fig. 1a and Supplementary Fig. 1a,b). First, 104 
to enable denaturing purification, we generated HEK293 cells stably expressing Flag-105 
tagged SmB and employed 6M urea during cell lysis to minimize co-purification of 106 
additional proteins11 (‘stringent’ purification, Supplementary Table 1), followed by 107 
dilution of the lysis buffer (see Methods) to facilitate immunopurification of SmB via the 108 
Flag tag. We observed a 25 kDa band corresponding to the molecular weight of SmB-109 
RNA complexes, which was absent when UV light or anti-Flag antibody were omitted, or 110 
when cells not expressing Flag-SmB were used (Supplementary Fig. 1c). Next, we 111 
employed the standard, non-denaturing iCLIP condition, which uses a high 112 
concentration of detergents in the lysis buffer, and wash buffer with 1M NaCl (‘medium’ 113 
purification, Supplementary Table 1). This disrupts most protein-protein interactions 114 
but can preserve stable complexes such as snRNPs, as evident by the multiple 115 
radioactive bands in addition to the 25 kDa SmB-RNA complex upon treatment with low 116 
RNase (Fig. 1b). Of note, similar profiles of protein-RNA complexes were obtained when 117 
using different monoclonal SmB/B' antibodies (Supplementary Fig. 1d). Last, we further 118 
decreased the concentration of detergents in the lysis buffer, used 0.1M NaCl in the 119 
washing buffer (‘mild’ purification, Supplementary Table 1), and employed the low 120 
RNase treatment that leaves snRNAs generally intact such that they serve as a scaffold 121 
for purifying the multi-protein spliceosomal complexes (Fig. 1a).  122 
To produce cDNA libraries with spliceosome iCLIP, we immunoprecipitated SmB/B' 123 
under the three different stringency conditions from lysates of UV-crosslinked cells, and 124 
isolated a broad size distribution of protein-RNA complexes in order to recover the 125 
greatest possible diversity of spliceosomal protein-RNA interactions (Fig. 1b and 126 
Supplementary Fig. 1c,d). An antibody against endogenous SmB/B' was used for 127 
medium and mild purification from HEK293, K562 and HepG2 cells, and an anti-Flag 128 
antibody for stringent purification from HEK293 cells expressing Flag-SmB 129 
(Supplementary Table 2 and 3). As in previous iCLIP studies6, the nucleotide preceding 130 
each cDNA was used for all analyses. When stringent conditions were used, >75% of 131 
iCLIP cDNAs mapped to snRNAs, likely corresponding to the direct binding of Flag-SmB 132 
(Fig. 1c). However, the proportion of snRNA crosslinking reduced to ~40-60% under 133 
mild and medium conditions, with a corresponding increase of crosslinking to introns 134 
and exons that likely reflects binding of snRNP-associated proteins to pre-mRNAs (Fig. 135 
1a,c). 136 
  5
Spliceosome iCLIP identifies seven crosslinking peaks on pre-mRNAs 137 
Assembly of the spliceosome on pre-mRNA is guided by three main landmarks: the 5'ss, 138 
3'ss and BP. Therefore, we evaluated if spliceosomal crosslinks are located at specific 139 
positions relative to splice sites and computationally predicted BPs12. For this purpose 140 
we performed spliceosome iCLIP from human Cal51 cells, which we have previously 141 
used as a model system to study the roles of spliceosomal factors in cell cycle5. RNA 142 
maps of summarized spliceosomal crosslinking revealed 7 peaks around these 143 
landmarks (Fig. 2a). Importantly, similar positional patterns were also seen in HEK293, 144 
K562 and HepG2 cell lines (Supplementary Fig. 2a). The centers of the peaks were 15 nt 145 
upstream of the 5'ss (peak 1), 10 nt downstream of the 5'ss (peak 2), 31 nt downstream 146 
of the 5'ss (peak 3), 26 nt upstream of the BP (peak 4), 20 nt upstream of the BP (peak 147 
5), 11 nt upstream of the 3'ss (peak 6) and 3 nt upstream of the 3'ss (peak 7). We also 148 
observed alignment of cDNA starts to the start of the intron and the BPs, which we refer 149 
to as positions A and B, respectively (Fig. 2a and Supplementary Fig. 2a). The 150 
crosslinking enrichment at most peaks was generally stronger under the mild condition, 151 
especially at the 3'ss (Supplementary Fig. 2a). This indicates that spliceosome iCLIP 152 
performed under mild conditions is most suitable for investigating spliceosomal 153 
assembly on pre-mRNAs. 154 
Spliceosome iCLIP monitors multiple stages of spliceosomal remodeling 155 
Next, we investigated whether spliceosome iCLIP is able to monitor spliceosome 156 
assembly at different stages during the splicing cycle. For this purpose we knocked 157 
down (KD) PRPF8 in Cal51 cells (Supplementary Fig. 2b) and performed spliceosome 158 
iCLIP under mild conditions. As an integral component of the U4/U6.U5 tri-snRNP, 159 
PRPF8 is essential for both catalytic reactions1. We previously showed that PRPF8 is 160 
required for efficient spliceosomal assembly at 5'ss5. Here, we additionally find that 161 
PRPF8 is essential for efficient spliceosomal assembly at peaks 4 and 5 (Fig. 2a). 162 
Moreover, we also observed a major decrease of reads truncating at the positions A and 163 
B, whereas crosslinking at peaks 2 and 6 is increased upon PRPF8 KD.  164 
To further investigate whether spliceosome iCLIP can monitor distinct stages of the 165 
splicing reaction, we performed an in vitro splicing assay in which an exogenous pre-166 
mRNA splicing substrate was incubated with HeLa nuclear extract in the presence or 167 
absence of ATP. ATP is required for the progression of early, ATP-independent, 168 
spliceosomal complexes to later assembly stages mediating the catalytic splicing 169 
reactions. The RNA substrate was produced by in vitro transcription of a minigene 170 
construct containing a short intron and flanking exons from the human C6orf10 gene. 171 
Gel electrophoresis analysis confirmed that the minigene RNA was efficiently spliced in 172 
vitro in an ATP-dependent manner (Supplementary Fig. 2c). We performed spliceosome 173 
iCLIP from the splicing reactions using the mild purification condition (Supplementary 174 
Fig. 2d). Following sequencing, the reads mapping to the exogenous splicing substrate or 175 
spliced product represented ~1%, whereas the remaining reads were derived from 176 
endogenous RNAs present in the nuclear extract (Supplementary Table 4). The spliced 177 
product was detected with exon-exon junction reads primarily in the presence of ATP 178 
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(364 reads in +ATP vs. 5 reads in -ATP condition) (Supplementary Fig. 2e and 179 
Supplementary Table 4). As expected given that the spliceosome rapidly disassembles 180 
upon completion of the splicing reaction, very few reads mapped to the spliced (364 181 
reads) compared to unspliced substrate (48,584 reads) (Supplementary Table 4) in the 182 
+ATP condition. It should be considered, however, that some reads from exogenous 183 
minigene could represent RNA that did not enter the splicing pathway. 184 
We visualized crosslinking on the substrate RNA, and marked positions that correspond 185 
to peaks on the transcriptome-wide RNA maps (Fig. 2b). Whilst crosslinking peaks on a 186 
metagene plot might not necessarily be representative of individual splicing substrates, 187 
we nevertheless observed crosslinking in corresponding regions of the C6orf10 188 
substrate (comparing Fig. 2a and 2b). When comparing crosslinking in the presence or 189 
absence of ATP, an unchanged crosslinking profile was seen in regions of peaks 1, 2, 6 190 
and 7, indicating these are ATP-independent contacts of early spliceosomal factors. In 191 
contrast, the presence of ATP led to a ~11 fold increase of crosslinking in the region 192 
upstream of the BP where the PRPF8-dependent peaks 4 and 5 are located on 193 
endogenous transcripts (Fig. 2b). This indicates that spliceosome iCLIP detects pre-194 
mRNA binding of factors contributing to early, ATP-independent and late, ATP-195 
dependent stages of spliceosomal assembly. 196 
Following crosslinking, the peptide that remains bound to the RNA after RBP digestion 197 
will normally terminate reverse transcription to produce so-called ‘truncated cDNAs’13-198 
15. Accordingly, analysis of data from iCLIP and derived methods, such as eCLIP16, 199 
generally refer to the nucleotide preceding the iCLIP read on the reference genome as 200 
the ‘crosslink site’. However, in spliceosome iCLIP we additionally expect cDNAs that 201 
truncate at the three-way junction formed by intron lariats, where the 5' end of the 202 
intron is linked via a 2'-5' phosphodiester bond to the BP (Fig. 2c). Following RNase 203 
digestion, such lariat three-way-junction RNAs present two available 3' ends for ligation 204 
of adapters, such that cDNAs can truncate at the BP (i.e. position B) or at the start of the 205 
intron (i.e. position A). Interestingly, the medium purification condition was optimal to 206 
produce cDNAs truncating at positions A and B (Supplementary Fig. 2a), possibly 207 
because spliceosomal C complexes containing lariat intermediates are known to be 208 
stable under high-salt conditions17. Note that peaks A and B are higher in HEK293 209 
compared to HepG2 and K562 cells under medium purification conditions, and likely 210 
reflect differences in lariat co-purification. Meanwhile, the number of cDNAs truncating 211 
at the positions A and B is dramatically decreased under conditions that inhibit splicing 212 
progression and lariat formation: PRPF8 KD in vivo (2-fold, Fig. 2a), or absence of ATP in 213 
vitro (≥18-fold, Fig. 2b). This further confirms that spliceosome iCLIP can monitor 214 
spliceosome assembly at distinct stages of the splicing cycle. 215 
 216 
Specific RBPs are enriched at each peak of spliceosomal crosslinking 217 
Next, to identify RBPs that crosslink at peaks identified by spliceosome iCLIP, we 218 
examined the eCLIP data for 110 RBPs (from 157 eCLIP samples of 68 RBPs in the 219 
HepG2, and 89 RBPs in the K562 cell line) provided by the ENCODE consortium16. Of 220 
note, comparisons between iCLIP and eCLIP are justified due to their use of identical 221 
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lysis and wash buffers (analogous to medium stringency from the present study), use of 222 
truncated cDNAs to identify crosslink sites and similar RNase digestion conditions, and 223 
comparable crosslinking profiles for RBPs such as PTBP1 and U2AF215. Accordingly, we 224 
analyzed the eCLIP data to identify RBPs with enriched normalized crosslinking at each 225 
spliceosomal iCLIP peak. This identified a specific set of RBPs at each peak, with good 226 
overlap between RBPs identified in K562 and HepG2 cells (Fig. 3 and Supplementary 227 
Data Set 1). As expected, SF3 components SF3B4, SF3A3 and SF3B1 bind to peaks 4 or 228 
518, U2AF2 binds the polypyrimidine (polyY) tract (peak 6), and U2AF1 close to the 229 
intron-exon junction (peak 7)19. 230 
Spliceosome iCLIP identifies BPs with canonical sequence and structural features 231 
To determine whether spliceosome iCLIP could experimentally identify human BPs, we 232 
used spliceosome iCLIP data produced under medium purification from Cal51 cells. 233 
Most cDNA starts in spliceosome iCLIP overlap with a uridine-rich motif (Fig. 4a), in 234 
agreement with an increased propensity of protein-RNA crosslinking at uridine-rich 235 
sites14. In contrast, cDNAs ending at the last nucleotide of introns, which are thus likely 236 
derived from intron lariats, have starts overlapping the YUNAY motif matching the 237 
consensus BP sequence (Fig. 4b). Further, these cDNAs have higher enrichment of 238 
mismatches of adenosines at their first nucleotide (Supplementary Fig. 3a), which is 239 
consistent with mismatch, insertion and deletion errors during reverse transcription 240 
across the three-way junction of the BP9. For comparison, reads that start in regions 241 
where BPs are typically located, but which do not align with intron ends, have less 242 
enrichment of the BP consensus motif at their starts (Supplementary Fig. 3b,c). To 243 
identify a confident set of putative BPs in a transcriptome-wide manner, we therefore 244 
used the spliceosome iCLIP cDNAs that aligned with the end of introns (Fig. 4b). These 245 
cDNAs started at adenines in 132,287 intronic positions, which we considered as BP 246 
candidates. The 41 read-length limited our analysis to the region where most BPs are 247 
located, but more distal BPs cannot be identified by this approach. For further study, we 248 
selected BPs with the highest number of truncated cDNAs per intron. This identified 249 
candidate BPs in 43,637 introns of 9,565 genes. 250 
To examine the BPs identified by spliceosome iCLIP (‘iCLIP BPs’), we compared them 251 
with the ‘computational BPs’ recently identified with a sequence-based deep learning 252 
predictor, LaBranchoR, which predicted BPs for over 90% of 3'ss12. We also compared 253 
with ‘RNA-seq BPs’, including the 138,314 BPs from 43,637 introns that were identified 254 
by analysis of lariat-spanning reads from 17,164 RNA-seq datasets8. Initially, 65% of 255 
iCLIP BPs overlapped with the top-scoring computational BPs (Supplementary Fig. 3d). 256 
Interestingly, in cases where iCLIP and computational BPs were located <5 nt apart, they 257 
frequently occurred within A-rich sequences (Supplementary Fig. 3e). This mismatch 258 
could be of technical nature, as truncation of iCLIP cDNAs may not always be precisely 259 
aligned to the BPs in case of A-rich sequences. Alternatively, more than one A might be 260 
capable of serving as the BP. When allowing a 1 nt shift for comparison between 261 
methods, as has been done previously12, 70% of iCLIP BPs overlapped with the top-262 
scoring computational BPs, whilst 26% overlapped with the RNA-seq BPs (Fig. 4c, 263 
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Supplementary Data Set 2). If the computational BPs overlapped either with an iCLIP BP 264 
and/or RNA-seq BP, it generally had a strong BP consensus motif (o-BP, Fig. 4d). 265 
To gain insight into the differences between the methods, we focused on BPs that were 266 
identified by a single method and located >5 nt away from BPs identified by other 267 
methods. Notably, the computational- or iCLIP-specific BPs have a strong enrichment of 268 
the consensus YUNAY motif (c-BP, i-BP, Fig. 4e,f,h,i). In contrast, RNA-seq-specific BPs 269 
contain a larger proportion of non-canonical BP motifs, which agrees with previous 270 
observations7,9,12 (Fig. 4g,j). To evaluate further, we compared iCLIP BPs with two 271 
studies that identified 59,359 BPs by exoribonuclease digestion and targeted RNA-272 
sequencing9, and 36,078 BPs by lariat-spanning reads refined by U2 snRNP/pre-mRNA 273 
base-pairing models7. Considering the introns that contained BPs defined both by RNA-274 
seq and iCLIP, we found 57% and 47% overlapping BPs (Supplementary Fig. 3f-i). Again, 275 
the iCLIP-specific BPs were more strongly enriched in the consensus YUNAY motif 276 
compared to BPs specifically identified by either RNA-seq method (Supplementary Fig. 277 
3j-o). We also examined the local RNA structure around each category of BPs. 278 
Overlapping, iCLIP-specific and computational-specific BPs had a decreased pairing 279 
probability at the position of the BP, which was not seen for the RNA-seq-specific BPs 280 
(Fig. 4k,l). The difference in RNA-seq BPs derives from the presence of non-canonical, 281 
non-A branched BPs, which have a generally increased pairing probability 282 
(Supplementary Fig. 3p,q). This indicates that the non-A BPs might be structurally less 283 
accessible for pairing with U2 snRNP. 284 
Alignment of RBP binding profiles signifies the functionality of BPs 285 
Peaks 4, 5 and position B align to BP position, and therefore we could evaluate how the 286 
crosslinking profiles of RBPs binding at these peaks align to the different classes of BPs.  287 
First, we examined the crosslinking of SF3B4, which binds in the region of peak 4 as part 288 
of the U2 snRNP complex that recognises the BP1. Analysis of the overlapping BPs (o-BP) 289 
defines the peak of SF3B4 crosslinking at the 25th nt upstream of BPs (Fig. 5 and 290 
Supplementary Fig. 4a,b). However, the peak of SF3B4 crosslinking is shifted from this 291 
25th position for the non-overlapping, method-specific BPs; it is generally closer than 25 292 
nt to the BPs located upstream of another BP (up BP), and further than 25 nt away from 293 
BPs located downstream of another BP (down BP) (Fig. 5). The shift from the expected 294 
position is greatest for RNA-seq-specific BPs (R-BP), and smallest for computationally 295 
predicted BPs, as evident by eCLIP data from two cell lines (Fig. 5a,b). Moreover, the 296 
same result is seen with U2AF2, where the strongest shift away from expected positions 297 
is seen for RNA-seq BPs, and weakest for computational BPs (Supplementary Fig. 4c,d). 298 
The cDNA starts from PRPF8 eCLIP are highly enriched at position B, corresponding to 299 
the lariat-derived cDNAs that truncate at BPs (Fig. 3). Interestingly, the PRPF8 cDNA 300 
starts had the strongest peak at the overlapping BPs, but also peaked at all the 301 
remaining classes of BPs (Supplementary Fig. 4e,f). This indicates that all classes of BPs 302 
contribute to lariat formation, and that the non-overlapping BPs most likely act as 303 
alternative BPs within the introns. 304 
Effects of BP position on spliceosomal assembly 305 
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To assess how BP positioning determines spliceosome assembly, we evaluated binding 306 
profiles of the RBPs that are enriched at peaks 4-7 and at positions A and B (Fig. 3). We 307 
divided BPs based on their distance from 3'ss, and normalized RBP binding profiles 308 
within each subclass of BP. This showed that crosslinking of U2AF1 and U2AF2 aligns to 309 
the region between the BPs and 3'ss, which is covered by the polyY tract 310 
(Supplementary Fig. 5 and 6). Whilst SF3B4 is the primary RBP crosslinking at peak 4, 311 
and SF3A3 at peak 5, binding of SMNDC1, SF3B1, EFTUD2, BUD13, GPKOW and XRN2 to 312 
peaks 4 and 5 was also evident (Supplementary Fig. 5, 6 and Fig. 3). PRPF8, RBM22 and 313 
SUPV3L1 have their cDNA starts truncating at positions A and B (Supplementary Fig. 5 314 
and 6), corresponding to the three-way junction formed by intron lariats (Fig. 2c). This 315 
is in agreement with the association of PRPF8 and RBM22 with intron lariats as part of 316 
the human catalytic step I spliceosome1. The positions of SF3B4 and SF3A3 crosslinking 317 
peaks also agree with CryoEM studies of the human spliceosome that show closer pre-318 
mRNA binding of SF3A3 (also referred to as SF3a60) to the BP compared to SF3B4 (also 319 
referred to as SF3b49)20.  320 
In order to quantify how BP positioning affects the intensity of RBP binding, we divided 321 
BPs into 10 equally sized groups based on the distance from 3'ss. We then normalized 322 
the relative binding intensity of each RBP at each position on the RNA maps across the 323 
ten groups, and revealed strong relationships between BP position and binding intensity 324 
of certain RBPs (Fig. 6a, Supplementary Fig. 7a). For example, if a BP is located distally 325 
from the 3'ss, then U2AF components bind stronger to peaks 6 and 7. In contrast, if a BP 326 
is located proximally to the 3'ss, then EFTUD2, SF3 components and several other RBPs 327 
bind stronger to the peaks 4 or 5 (Fig. 6b). Notably, increased BP distance causes 328 
increased binding of BUD13 and GPKOW at peaks 6 or 7 and decreased binding at peaks 329 
4 and 5. The more efficient recruitment of U2AF and associated factors to peaks 6 and 7 330 
could be explained by the long polyY-tracts at distal BPs (Supplementary Fig. 5), while 331 
their decreased binding at proximal BPs appears to be compensated by increased 332 
binding of SF3 and other U2 snRNP-associated factors at peaks 4 and 5. 333 
In contrast to effects on individual splicing factors, we did not observe any effect of BP 334 
distance on the relative intensity of spliceosome iCLIP crosslinking in peaks 4 and 5 335 
compared to 6 and 7 (Fig. 6c). This indicates that the effects may be masked during later 336 
stages of spliceosome assembly. To ask if this is the case, we turned to PRPF8, a protein 337 
that is essential for later stages of spliceosomal assembly, a role it plays together with 338 
EFTUD2 and BRR2 as part of U5 snRNP1. PRPF8 KD leads to decreased spliceosomal 339 
binding at peaks 4 and 5, and this effect is stronger at distal compared to proximal BPs 340 
(Fig. 6c). In conclusion, our results reveal differences in the binding profiles of splicing 341 
factors in relation to BP distance, but these differences are neutralized upon full 342 
spliceosome assembly in a manner that requires the presence of PRPF8. 343 
Effects of BP strength on spliceosomal assembly 344 
To examine how BP strength affects spliceosomal assembly we focused on BPs that have 345 
been identified both by spliceosome iCLIP and computational modelling, and which are 346 
located at 23-28 nt upstream of the 3'ss. Of note, this is the most common position of 347 
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BPs (Supplementary Data Set 3). As an estimate of BP strength we used the BP score, 348 
which was determined with a deep-learning model12. This showed strong correlation 349 
between BP strength and RBP binding intensities, such that most RBPs have increased 350 
crosslinking at peaks 4 and 5 at BPs with very high scores, and, conversely, increased 351 
crosslinking at peaks 6 and 7 at BPs with very low scores (Fig. 7a,b, Supplementary Fig. 352 
7b). Since SF3 components primarily bind at peaks 4 and 5, and U2AF components at 353 
peaks 6 and 7, an over 4-fold change is seen in the ratio of crosslinking when comparing 354 
the extreme deciles of BP strength (Supplementary Fig. 7c). We did not observe any 355 
correlation between the polyY tract coverage and BP score (Supplementary Fig. 7d), 356 
which indicates that BP strength directly affects the RBP binding profiles. 357 
Similar to the effects on individual splicing factors, the relative intensity of spliceosome 358 
iCLIP crosslinking in peaks 4 and 5 was increased with increasing BP strength (Fig. 7c, 359 
compare blue lines on the left and right graphs). PRPF8 KD decreased spliceosomal 360 
binding at peaks 4 and 5 of both classes of BPs, and this led to stronger crosslinking at 361 
peaks 6 and 7 relative to peaks 4 and 5 at weak BPs, even though the peaks 4 and 5 are 362 
usually stronger. The signal at position B of weak BPs is almost completely lost upon 363 
PRPF8 KD, which likely reflects the absence of intron lariats due to perturbed splicing of 364 
introns with weak BPs (Fig. 7c). In conclusion, our results suggest that the assembly 365 
efficiency of spliceosomal factors at peaks 4 and 5 closely correlates with BP strength, 366 
which indicates that recognition of weak BPs might be more sensitive to perturbed 367 
spliceosome function. 368 
 369 
Discussion 370 
Here we established spliceosome iCLIP to study the interactions of endogenous snRNPs 371 
and accessory splicing factors on pre-mRNAs. We identified peaks of spliceosomal 372 
protein-pre-mRNA interactions, which precisely overlap with crosslinking profiles of 15 373 
splicing factors. Interestingly, the contacts of RBPs in peaks 4 and 5 don’t overlap with 374 
any sequence motif, and thus the constrained conformation of the larger spliceosomal 375 
complex appears to act as a molecular ruler that positions each associated RBP on pre-376 
mRNAs at a specific distance from BPs. Moreover, the presence of lariat-derived reads in 377 
spliceosome iCLIP identified >40,000 BPs that have canonical sequence and structural 378 
features. Due to the precise alignment of splicing factors relative to the positions of BPs, 379 
we could use their binding profiles to show that the assembly of U2 snRNP is primarily 380 
coordinated by the computationally predicted BPs, whilst alternative BPs, identified 381 
only by iCLIP or RNA-seq, are more rarely used. Finally, we reveal the major effect of the 382 
position and strength of BPs on spliceosomal assembly, which can explain why distally 383 
located or weak BPs are particularly sensitive to perturbed spliceosome function upon 384 
PRPF8 KD. These findings demonstrate the broad utility of spliceosome iCLIP for 385 
simultaneous and transcriptome-wide analysis of the assembly of diverse spliceosomal 386 
components. 387 
The value of spliceosome iCLIP for identifying BPs 388 
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Both RNA-seq and iCLIP identify BPs by analyzing cDNAs derived from intron lariats. 389 
Thus, the efficiency of these methods depends on the abundance of intron lariats, which 390 
depends on the kinetics of lariat debranching. Several studies demonstrated that lariats 391 
formed at non-canonical BPs are less efficiently debranched21-23, and therefore these 392 
non-canonical BPs are expected to be more efficiently detected. This is especially true 393 
for RNA-seq-based methods, because they monitor steady state RNA levels. In contrast, 394 
iCLIP only captures lariats in complex with spliceosomes, thus minimizing bias for 395 
lariats that are stable after their release from the spliceosome. This could explain why 396 
the BPs identified by iCLIP contain a stronger consensus sequence than BPs identified 397 
from lariat-spanning reads in RNA-seq. The further value of spliceosome iCLIP is that, in 398 
addition to experiments under the medium condition that permit BP identification 399 
through lariat-derived cDNAs, experiments under the mild condition identify the SF3 400 
complex and other U2 snRNP-associated RBPs that crosslink at peaks 4 and 5. These can 401 
crucially be used to independently validate the functional role of BPs in the assembly of 402 
U2 snRNP. Thus, use of spliceosome iCLIP under both conditions, combined with 403 
computational modelling of BPs12, is well suited to studying the functionality of BPs. 404 
The role of BP position and strength in spliceosomal assembly 405 
We show that BP position and the computationally defined strength of BPs correlate 406 
with the relative binding of splicing factors around BPs. This is exemplified by strong 407 
binding of SF3 components at strong BPs, or BPs located close to 3'ss, whilst U2AF 408 
components bind stronger to weak BPs, or BPs located further from 3'ss (Fig. 7d). In the 409 
cases of SF3B1, BUD13 and GPKOW, we observed enriched binding at peaks 4 and 5 as 410 
well as 6 and 7, with reciprocal changes between the two peak regions dependent on BP 411 
features (Fig. 6 and 7). These RBPs are not known to bind at peaks 6 or 7, and it is 412 
plausible that the signal at some peaks represents binding of U2AF or other 413 
spliceosomal factors that are co-purified during eCLIP. It is presently not possible to 414 
fully distinguish between direct and indirect binding from eCLIP data, because purified 415 
protein-RNA complexes have not been visualized after their separation on SDS-PAGE 416 
gels in eCLIP13. Nevertheless, it is clear that BP characteristics determine the balance 417 
between binding of SF3 and associated factors at peaks 4 and 5 and of U2AF and 418 
associated factors at peaks 6 and 7. This suggests further study of RBP binding profiles 419 
around BPs could unravel a BP ‘code’ that facilitates specific stages of BP recognition 420 
and function. 421 
In conclusion, spliceosome iCLIP monitors concerted pre-mRNA binding of many types 422 
of spliceosomal complexes with nucleotide resolution, allowing their simultaneous 423 
study due to the distinct position-dependent binding pattern of components acting at 424 
multiple stages of the splicing cycle. The method can now be used to study the 425 
endogenous spliceosome and BPs across tissues, species and stages of development 426 
without need for the protein tagging used in yeast3,4. Further, several spliceosomal 427 
components, including U2AF1, SF3B1 and PRPF8, are targets for mutations in myeloid 428 
neoplasms, retinitis pigmentosa and other diseases24. Spliceosome iCLIP could now be 429 
used to monitor global impacts of these mutations on spliceosome assembly in human 430 
cells. More generally, our study demonstrates the value of iCLIP for monitoring the 431 
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position-dependent assembly and dynamics of multi-protein complexes on endogenous 432 
transcripts. 433 
 434 
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Figure legends 527 
Fig. 1 | Spliceosome iCLIP identifies protein interactions with snRNAs and splicing 528 
substrates.  529 
(a) Schematic representation of the spliceosome iCLIP method performed under 530 
conditions of varying purification stringency. 531 
(b) Autoradiogram of crosslinked RNPs immunopurified from HeLa cells under medium 532 
conditions by a SmB/B' antibody following digestion with high (++) or low (+) amounts 533 
of RNase I. The dotted line depicts the region typically excised from the nitrocellulose 534 
membrane for spliceosome iCLIP. As control, the antibody (Ab) was omitted during 535 
immunopurification. 536 
(c) Genomic distribution of spliceosome iCLIP cDNAs produced under stringent, medium 537 
and mild conditions from HEK293 cells. Data was mapped first to snRNAs, allowing 538 
multiple mapping reads, and then to the genome, allowing only uniquely mapped reads. 539 
Proportions of cDNAs mapping to snRNAs, introns, coding sequence of mRNAs (CDS), 540 
untranslated regions of mRNAs (UTR) and long non-coding RNAs (lncRNAs) are shown 541 
(but not the intergenic reads and other types of RNAs). Data are shown as mean±s.e.m 542 
from three independent experiments for the medium and mild purification condition 543 
and two independent experiments for the stringent purification condition. Source data 544 
for panel c are available online. 545 
 546 
Fig. 2 | Analysis of spliceosomal interactions with pre-mRNAs in vitro and in vivo. 547 
(a) Metagene plots of spliceosome iCLIP from Cal51 cells. Plots are depicted as RNA 548 
maps of summarized crosslinking at all exon-intron and intron-exon boundaries, and 549 
around BPs to identify major binding peaks, and to monitor changes between control 550 
and PRPF8 knockdown (KD) cells. Crosslinking is regionally normalized to its average 551 
crosslinking across the -100..50 nt region relative to splice sites or BPs depending on the 552 
RNA map in order to focus the comparison on the relative positions of peaks. 553 
(b) Normalized spliceosome iCLIP cDNA counts on the C6orf10 in vitro splicing 554 
substrate. Exons are marked by grey boxes, intron by a line, and the BP by a green dot. 555 
The positions of crosslinking peaks are marked by numbers and letters corresponding 556 
to the peaks in Figure 2a. 557 
(c) Schematic description of the three-way junctions of intron lariats. The three-way 558 
junction is produced after limited RNase I digestion of intron lariats. This can lead to 559 
cDNAs that don’t truncate at sites of protein-RNA crosslinking, but rather at the three-560 
way junction of intron lariats. These cDNAs initiate from the end of the intron and 561 
truncate at the BP (position B), or initiate downstream of the 5'ss and truncate at the 562 
first nucleotide of the intron (position A). 563 
 564 
Fig. 3 | Identification of RBPs overlapping with spliceosomal peaks at BPs and 3'ss. 565 
Enrichment of eCLIP crosslinking within each of the spliceosome iCLIP peaks, which are 566 
defined by the positions marked in the figure. We first regionally normalized the 567 
crosslinking of each RBP to its average crosslinking over -100..50 nt region relative to 568 
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3'ss, which generates the RNA maps as shown in Supplementary Fig. 5 and 6. We then 569 
ranked the RBPs according to the average normalized crosslinking across the 570 
nucleotides within each peak. We analyzed peaks 4-7 and positions A and B, as marked 571 
on the top of each plot. The top-ranking RBPs in each peak are shown on the left plot, 572 
and the full distribution of RBP enrichments is shown on the right plot. 573 
 574 
Fig. 4 | Comparison of BPs identified by spliceosome iCLIP, RNA-seq lariat reads or 575 
computational prediction. 576 
(a) Weblogo around the nucleotide preceding all spliceosome iCLIP reads.   577 
(b) Weblogo around the nucleotide preceding only those spliceosome iCLIP reads that 578 
align with ends of introns. 579 
(c) Introns that contain at least one BP identified either by published RNA-seq8 or by 580 
spliceosome iCLIP are used to examine the overlap between the top BPs identified by 581 
RNA-seq (i.e., the BP with most lariat-spanning reads in each intron), iCLIP (BP with 582 
most cDNA starts) or computational predictions (highest scoring BP)12. BPs that are 0 or 583 
1 nt apart are considered as overlapping. At the right, BP categories that are used for all 584 
subsequent analyses are defined, along with their acronyms. If a BP defined by one 585 
method is >5 nt upstream of a BP defined by another method, then ‘up’ is added to its 586 
acronym, and if it is >5 nt downstream, ‘down’ is added. 587 
(d) Weblogo of o-BP category of BPs. 588 
(e) Weblogo of C-BPup category of BPs.  589 
(f) Weblogo of i-BPup category of BPs.  590 
(g) Weblogo of R-BPup category of BPs.  591 
(h) Weblogo of C-BPdown category of BPs.  592 
(i) Weblogo of i-BPdown category of BPs.  593 
(j) Weblogo of R-BPdown category of BPs.  594 
(k, l) The 100 nt RNA region centered on the BP was used to calculate pairing 595 
probability with the RNAfold program using default parameters25, and the average 596 
pairing probability of each nucleotide around BPs is shown for the 40 nt region around 597 
method-specific BPs located upstream (k) or downstream (l). 598 
 599 
Fig. 5 | Spliceosome assembly at BPs identified by spliceosome iCLIP, RNA-seq 600 
lariat reads or computational prediction. 601 
Violin plots depicting the positioning of SF3B4 cDNA starts relative to the indicated BP 602 
categories. SF3B4 eCLIP data were from K562 (a) and HepG2 (b) cells. Box-plot 603 
elements are defined by center line, median; box limits, upper and lower quartiles; and 604 
whiskers, 1.5× interquartile range. Each data point corresponds to an eCLIP crosslink 605 
event, and the total number of eCLIP crosslinks that map in the area analysed around 606 
each set of BPs (sample size) is shown under the plot. 607 
 608 
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Fig. 5 | Spliceosome assembly at BPs identified by spliceosome iCLIP, RNA-seq 609 
lariat reads or computational prediction. 610 
Violin plots depicting the positioning of SF3B4 cDNA starts relative to the indicated BP 611 
categories. SF3B4 eCLIP data were from K562 (a) and HepG2 (b) cells. Box-plot 612 
elements are defined by center line, median; box limits, upper and lower quartiles; and 613 
whiskers, 1.5× interquartile range. 614 
 615 
Fig. 6 | BP position defines the binding patterns of splicing factors at 3'ss. 616 
(a) Heatmaps depicting the normalized crosslinking of RBPs in peak regions around 10 617 
groups of BPs that were categorized according to the distance of the BP from 3'ss. 618 
Crosslinks were derived as cDNA starts from eCLIP of HepG2 cells. 619 
(b) RNA maps showing normalized crosslinking profiles of selected RBPs relative to BPs 620 
and 3'ss for the two deciles of BPs that are located most proximal (interrupted light 621 
lines) or most distal (solid dark lines) from 3'ss.  622 
(c) RNA maps showing crosslinking profile of spliceosome iCLIP from control and PRPF8 623 
KD Cal51 cells in the same format as panel b. 624 
 625 
Fig. 7 | BP strength correlates with the binding of splicing factors. 626 
(a) Heatmaps depicting the normalized crosslinking of RBPs in peak regions around 10 627 
groups of BPs that were categorized according to the computational scores that define 628 
BP strength. Crosslinks were derived as cDNA starts from eCLIP of HepG2 cells. 629 
(b) RNA maps showing normalized crosslinking profiles of selected RBPs relative to 3'ss 630 
for the two deciles of BPs that are lowest scoring (interrupted light lines) or highest 631 
scoring (solid dark lines).  632 
 (c) RNA maps showing crosslinking profile of spliceosome iCLIP from control and 633 
PRPF8 KD Cal51 cells in the same format as panel b. 634 
(d) Schematic representation of the effects that BP position and score have on the 635 
assembly of SF3 and U2AF complexes around BPs. 636 
 637 
 638 
 639 
Online Methods 640 
Cell culture 641 
Flp-In HEK293 T-REx cells were from ThermoFisher (R78007), K562, HepG2 and 642 
standard HEK293 cells were obtained from the Francis Crick Cell Services Science 643 
Technology Platform,  and Cal51 breast adenocarcinoma cells were obtained from DSMZ 644 
(reference 14563). All cell lines tested negative for Mycoplasma contamination. HEK293 645 
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and HepG2 were cultured in DMEM with 10% FBS (ThermoFisher) and 1× penicillin-646 
streptomycin (ThermoFisher). K562 cells were cultured in RPMI 1640 (IMDM, ATCC) 647 
with 10% FBS and 1× penicillin-streptomycin. Cal51 cells were cultured in DMEM 648 
(ThermoFisher) with 10% fetal calf serum (FCS, ThermoFisher) and 1× penicillin-649 
streptomycin (ThermoFisher). 650 
To generate a plasmid encoding 3×Flag epitope-tagged SmB, the SmB cDNA was 651 
amplified using Phusion High-Fidelity DNA polymerase (NEB) with primers carrying the 652 
KpnI and NotI restriction enzymes sites and cloned using Rapid DNA Ligation Kit 653 
(Thermo Fisher Scientific) into a pcDNA5/FRT/TO vector modified to encode 3×Flag 654 
peptide upstream of the multiple cloning site. To produce stable cell lines expressing 655 
this construct, the pcDNA5/FRT/TO plasmid with 3×Flag epitope-tagged SmB was co-656 
transfected with pOG44 plasmid into Flp-In HEK293 T-REx cells (ThermoFisher, 657 
R78007). Cells stably expressing these proteins were selected by culturing in Dulbecco’s 658 
Modified Eagle Medium (DMEM, Thermofisher) containing 10% fetal bovine serum 659 
(FBS), 3 μg/ml Blasticidine S HCl, 200 μg/ml Hygromycine (InvivoGen). Flp-In 293 T-660 
REx cells (Life Technologies) were cultured in DMEM with 10% FBS, 3 μg/ml Blasticidin 661 
S HCl (Life Technologies), 50 μg/ml Zeocin (Life Technologies). Doxycycline was added 662 
to media 24 hours prior to sample preparation in order to induce construct expression.  663 
Cal51 breast adenocarcinoma cells were prepared as described previously5. For siRNA-664 
mediated depletion of PRPF8, Cal51 cells were transfected using DharmaFECT1 665 
(Dharmafect) with 25 nM siRNA targeting human PRPF8. Transfected cells were 666 
harvested 54 hrs later, exposed to UV-C light and used for iCLIP as described below. For 667 
collection of samples from different stages of the cell cycle, Cal51 cells were 668 
synchronized in G1/S by standard double thymidine block. Briefly, cells were treated 669 
with 1.5 mM thymidine for 8 hrs, washed and released for 8 hrs, then treated again with 670 
thymidine for a further 8 hrs. Cells were also collected 3 hrs (S-phase) and 7 hrs (G2) 671 
after release from the thymidine block. 672 
Antibody production 673 
For production of the anti-SmB/B’ monoclonal antibody 18F6, Balb/c females were 674 
primed with Immuneasy adjuvant (Qiagen) and 25 mg of 6×His-SmB purified 675 
recombinant proteins. Following two boosts at two-week intervals, SP2 myeloma cells 676 
were fused with mouse splenocytes and hybridoma supernatants were analyzed onto 677 
antigen-coated aminosilane modified slides using a LS400 Scanner (Tecan) and the 678 
GenePix Pro 4.1 software as described previously10. Hybridoma cells were subcloned by 679 
limiting dilution and further screened by ELISA, Western blot and immunofluorescence 680 
analysis of HeLa cells. 681 
In vitro splicing 682 
For in vitro splicing reactions, a C6orf10 minigene construct containing exon 8 and 9 and 683 
150 nt of the intron around both splice sites was produced (Fig. 2b). The minigene 684 
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plasmid was linearized and transcribed in vitro using T7 polymerase with 32P-UTP. The 685 
transcribed RNA was then subjected to in vitro splicing reactions using HeLa nuclear 686 
extract. HeLa nuclear extract was depleted of endogenous ATP by pre-incubation and, 687 
for each reaction, 10 ng of RNA was incubated with 60% HeLa nuclear extract at 30°C 688 
with or without additional 0.5 mM ATP for 1 h in a 20 µl reaction. Afterwards, the 689 
reaction mixture was UV-crosslinked at 100 mJ/cm2 and stored at -80°C until further 690 
use. To visualize the splicing reaction products, proteinase K was added to the reaction 691 
mixture for 30 min at 37°C. The resulting RNA was phenol-extracted, precipitated and 692 
subjected to gel electrophoresis on a 5% polyacrylamide-urea gel.  693 
Spliceosome iCLIP protocol  694 
For each experiment, three biological replicate samples of cDNA libraries were prepared 695 
(Supplementary Tables 2 and 3). The iCLIP method was done as previously described11, 696 
with the following modifications. Crosslinked cells or tissue were dissociated in the lysis 697 
buffer according to the stringency conditions (stringent, medium, mild; Supplementary 698 
Table 1) followed by sonication, low RNase I (AM2295, 100 U/µl, ThermoFisher) 699 
digestion and centrifugation. RNase at low concentration ensured that cDNAs are of 700 
optimal size for comprehensive crosslink determination15. For denaturing, high-701 
stringency experiment11, M2 anti-Flag antibody (Sigma) was used against the 3×Flag-702 
SmB protein that had been stably integrated into HEK-293 FlpIn cells (Supplementary 703 
Fig. 1c). 6M Urea buffer was first used to lyse cell pellets, before being diluted down 1:9 704 
with a Tween-20-containing IP buffer to allow for immunopurification without 705 
denaturing of the M2 anti-Flag antibody, and then proceeded as described previously15.  706 
Standard iCLIP protocol11 was used for Cal51 cells under mild and medium stringency 707 
conditions, and for the in vitro splicing reactions under mild conditions, whilst an 708 
updated protocol was used for HEK293, HepG2 and K562 cells26. For SmB/B' 709 
immunopurification anti-SmB/B' antibodies 12F5 (sc-130670, Santa Cruz Biotechnology 710 
for Cal51 cells, and S0698, Sigma-Aldrich for HEK293, HepG2 and K562 cells) or 18F6 711 
(as hybridoma supernatant, generated as described previously10) were used, which are 712 
different clones from the same immunization. These antibodies behave identically under 713 
immunopurification conditions (Supplementary Fig. 1d). For spliceosome iCLIP from in 714 
vitro splicing reactions (Supplementary Fig. 2c,d), lysates were incubated with 50 μl 715 
monoclonal anti-SmB/B' antibody 18F6, and for immunoprecipitations from cell lysates, 716 
12F5 anti-SmB/B' antibody was used. The antibody was bound to 100 μl protein G 717 
Dynabeads (ThermoFisher) under rotation at 4°C followed by washing. As described 718 
previously, following immunopurification, RNA 3' end dephosphorylation, ligation of the 719 
adapter 5'-rAppAGATCGGAAGAGCGGTTCAG/ddC/-3' to the 3' end and 5' end 720 
radiolabeling, protein-RNA complexes were size-separated by SDS-PAGE and 721 
transferred onto nitrocellulose membrane. The regions corresponding to 28-180 kDa 722 
were excised from the membrane in order to isolate the bound RNA by proteinase K 723 
treatment. RNAs were reverse-transcribed in all experiments using SuperScript III or IV 724 
reverse transcriptase (ThermoFisher) and custom indexed primers (Supplementary 725 
Table 2). Resulting cDNAs were subjected to electrophoresis on a 6% TBE-urea gel 726 
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(ThermoFisher) for size selection. Purified cDNAs were circularized, linearized and 727 
amplified for high-throughput sequencing. 728 
Identification of protein crosslink sites around splice sites, in particular at the peaks 4 729 
and 5, was most efficient under the mild purification condition (Supplementary Fig. 2a). 730 
This condition was therefore used for analysis of spliceosomal assembly upon PRPF8 731 
knockdown in Cal51 cells (Fig. 2a), and in the in vitro splicing reactions in HeLa nuclear 732 
extract (Fig. 2b). For the identification of BPs, we additionally used the medium 733 
condition, since it increases the frequency of cDNAs truncating at peak B 734 
(Supplementary Fig. 2a). For this purpose, spliceosome iCLIP was performed under 735 
medium purification conditions from Cal51 cells synchronized in G1, S and G2 phase. To 736 
maximize cDNA coverage, data from all synchronized cells was merged with the control 737 
Cal51 cells under mild condition for BP identification. 738 
Mapping of Sm iCLIP reads 739 
We mapped iCLIP data to the GRCh38 primary assembly and GENCODE v27 gene 740 
annotations using STAR (v.2.2.1). Experimental and random barcode sequences of iCLIP 741 
sequenced reads were removed prior to mapping (Supplementary Table 2). Following 742 
mapping, we used random barcodes to quantify the number of unique cDNAs at each 743 
genomic position by collapsing cDNAs with the same random barcode that mapped to 744 
the same starting position to a single cDNA. For analysis of crosslinking to snRNAs, we 745 
first mapped to a transcriptome of all annotated snRNA sequences in GENCODE v27 746 
using Bowtie2 (v2.3.4.3), and kept the primary alignment. Unmapped reads were then 747 
mapped with STAR as previously described and intersected with GENCODE v27 for 748 
subtype analysis, with reads from Bowtie2 being added to the total snRNA count. For 749 
spliceosome iCLIP with the C6orf10 in vitro splicing substrate, sequence reads were first 750 
mapped to the unspliced substrate and the remaining reads were mapped to the spliced 751 
substrate allowing no mismatches. The nucleotide preceding the iCLIP cDNAs was used 752 
to define the crosslink sites in all analyses.  753 
Mapping of eCLIP reads 754 
For eCLIP sequencing data for all RBPs, we used GENCODE (GRCh38.p7) genome 755 
assembly and the STAR alignment (version 2.4.2a) using the following parameters from 756 
ENCODE pipeline: STAR --runThreadN 8 --runMode alignReads --genomeDir GRCh38 757 
Gencode v25 --genomeLoad LoadAndKeep --readFilesIn read1, read2, --758 
readFilesCommand zcat --outSAMunmapped Within –outFilterMultimapNmax 1 --759 
outFilterMultimapScoreRange 1 --outSAMattributes All --outSAMtype BAM Unsorted –760 
outFilterType BySJout --outFilterScoreMin 10 --alignEndsType EndToEnd --761 
outFileNamePrefix outfile.  762 
For the PCR duplicates removal, we used a python script ’barcode collapse pe.py’ 763 
available on GitHub (https://github.com/YeoLab/gscripts/releases/tag/1.0), which is 764 
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part of the ENCODE eCLIP pipeline 765 
(https://www.encodeproject.org/pipelines/ENCPL357ADL/). 766 
Normalization of crosslink positions for their visualization in the form of RNA 767 
maps 768 
RNA maps and heat maps were produced by summarizing the cDNA counts at each 769 
nucleotide using the previously developed RNA maps pipeline15,27 relative to exon-770 
intron and intron-exon boundaries and BPs on pre-mRNAs. The definition of intronic 771 
start and end positions was based on Ensembl version 75. Only introns longer than 300 772 
nt were used to draw RNA maps in order to avoid detection of any RBPs that recognize 773 
5'ss of introns. 774 
In cases where we wished to compare the relative positions of crosslinking peaks 775 
between RBPs, we regionally normalized the summarized crosslinking of each RBP 776 
relative to the average crosslinking of the same RBP across the region 100 nt upstream 777 
and 50 nt downstream of the evaluated splice sites or BPs. Normalized values were then 778 
used to visualize the crosslinking in the form of RNA maps (Fig. 2, Supplementary Fig. 5 779 
and 6). The same normalization was then used to plot heat maps, by plotting mean 780 
values of normalized RNA maps for each peak in the following regions; peak 4: -29..-23 781 
nt and peak 5: -21..-17 nt relative to BP, peak 6: -11..-5 nt and peak 7: -3..-1 nt relative to 782 
3'ss. Every RBP was then normalized by the mean across all the peaks to visualize 783 
crosslinking enrichment between the groups on the same scale across all RBPs (Fig. 6 784 
and 7, Supplementary Fig. 7). 785 
To assess the role of BP characteristics on spliceosomal RBP assembly (Fig. 4, 6 and 7), 786 
we only examined the introns containing the 31,167 BPs that were identified both 787 
computationally and by iCLIP, which are likely the most reliable. We divided BPs into 10 788 
categories based on BP position or score, and then normalized the summarized 789 
crosslinking of each RBP in each of the 10 BP categories relative to the average 790 
crosslinking of the same RBP across the region 100 nt upstream and 50 nt downstream 791 
of all the 31,167 evaluated BPs. 792 
For visualization of spliceosome iCLIP crosslinks along the C6orf10 in vitro splicing 793 
substrate and product (Fig. 2b and Supplementary Fig. 2e) we first summed the cDNA 794 
starts at each nt position and then normalized the counts by the average number of 795 
cDNA starts in the intronic region 101..150 relative to the 5'ss of the unspliced 796 
substrate. For the unspliced substrate normalized cDNA counts were logarithmized 797 
(log2) and data with log2(normalized number of cDNA starts)≥1 were plotted. For the 798 
spliced product normalized cDNA counts were plotted. 799 
Identification and comparison of BPs 800 
It has been shown that the spliceosomal C complexes harbor a salt-resistant RNP core 801 
containing U2, U5 and U6 snRNAs as well as the splicing intermediates including lariats 802 
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that withstand treatment with 1M NaCl, whereas the spliceosomal B complexes were 803 
more likely dissociated under high-salt conditions17. This could explain why the medium 804 
purification condition is more suited than the mild condition to enrich for lariat cDNAs 805 
truncating at position B (Supplementary Fig. 2a). It is conceivable that the medium 806 
spliceosome iCLIP condition most strongly enriches spliceosomal C complexes, which 807 
are most effective for lariat detection. In contrast, the mild condition is expected to 808 
enrich additional B complexes that contain large amounts of SF3 components and have 809 
low proportion of lariats, in agreement with the strong enrichment of peaks 4 and 5 810 
(Supplementary Fig. 2a). To identify the maximal diversity of BPs, we therefore pooled 811 
spliceosome iCLIP data produced under mild and medium purification conditions from 812 
Cal51 cells. 813 
To identify BPs we used the spliceosome iCLIP reads that ended precisely at the ends of 814 
introns (we considered only introns that end in AG dinucleotide) after removal of the 3' 815 
adapter. We noticed that these reads had an 3.5× increased frequency of mismatches on 816 
the A as the first nucleotide compared to remaining iCLIP reads (Supplementary Fig. 3a), 817 
indicating that these mismatches may have resulted from truncation at the three-way-818 
junction formed at the BP (Fig. 2c). We therefore trimmed the first nucleotide from the 819 
read if it contained a mismatch at the first position that corresponded to a genomic 820 
adenosine. We then used spliceosome iCLIP from Cal51 cells to identify all reads that 821 
ended precisely at the ends of introns and defined the position where these reads 822 
started and assessed the random barcode nucleotides that are present at the beginning 823 
of each iCLIP read to count the number of unique cDNAs at each position. The nucleotide 824 
preceding the read start corresponds to the position where cDNAs truncated during the 825 
reverse transcription, and we selected the genomic A that had the highest number of 826 
truncated cDNAs as the candidate BP. If two positions with equal number of cDNAs were 827 
found, we selected the one closer to the 3'ss. Together, this identified 43,637 BPs.  828 
We also attempted to use truncated cDNAs from PRPF8 eCLIP for discovery of BPs, but 829 
found that the number of cDNAs overlapping with intron ends was much smaller than in 830 
spliceosome iCLIP, and was insufficient for BP discovery. This is most likely because of 831 
the high amount of non-specific background signal in PRPF8 eCLIP, which leads to a 832 
lower proportion of cDNAs that align to the BPs. 833 
Bedtools Intersect command using option –u was used to compare BP coordinates from 834 
spliceosome iCLIP to the BPs identified in previous studies. We restricted this 835 
comparison to introns where BPs were detected by all three datasets (iCLIP, RNA-seq 836 
and computational prediction). 837 
To define a single ‘computational BP’ per intron, the BP positions computationally 838 
predicted for each intron in hg19 were obtained from 839 
http://bejerano.stanford.edu/labranchor/, and the top scoring BP in each intron was 840 
used. To define a single ‘RNA-seq BP’ per intron, we used the BP with most lariat-841 
spanning reads in each intron.  842 
Analysis of pairing probability 843 
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Computational predictions of the secondary structure were performed by RNAfold 844 
function from Vienna Package (https://www.tbi.univie.ac.at/RNA/) with default 845 
parameters25. The RNAfold results are provided in a customized format, where brackets 846 
are representing the double-stranded region on the RNA and dots are used for unpaired 847 
nucleotides. We measured the density of pairing probability by summing the paired 848 
positions into a single vector. 849 
Identification of RBPs overlapping with spliceosomal peaks 850 
For RBP enrichment in Fig. 3, we used the eCLIP data from the ENCODE consortium16, 851 
together with available iCLIP experiments from our lab (which are all listed in 852 
Supplementary Data Set 4), to see if any of the proteins are enriched in the region of 853 
spliceosomal peaks. In total, this included 157 eCLIP samples of 68 RBPs in the HepG2 854 
cell line, and 89 RBPs in the K562 cell line, and iCLIP samples of 18 RBPs from different 855 
cell lines (Supplementary Data Set 4). Next, we intersected cDNA starts from each 856 
sample to the -100 to +50 nt region relative to the 3'ss and used it as control for each of 857 
the following peaks: Peak 4 (-23 nt..-29 nt relative to BP), Peak 5 (-21 nt..-17 nt relative 858 
to BP), Peak B (-1 nt..1 nt relative to BP), Peak A (-1 nt..1 nt relative to 5'ss), Peak 6 (-11 859 
nt..-10 nt relative to 3'ss), Peak 7 (-3 nt..-2 nt relative to 3'ss). The positions of these 860 
peaks were determined based on crosslink enrichments in spliceosome iCLIP. 861 
Statistics 862 
All statistical analyses were performed in the R software environment (version 3.1.3 and 863 
3.3.2, https://www.r-project.org). 864 
Reporting Summary 865 
Further information on experimental design is available in the Nature Research 866 
Reporting Summary linked to this article. 867 
Code availability 868 
The code to identify BPs from spliceosome iCLIP reads is publicly available at the GitHub 869 
repository (https://github.com/nebo56/branch-point-detection-2). 870 
Data availability 871 
The spliceosome iCLIP data generated and analyzed during the current study are 872 
available on EBI ArrayExpress under the accession number E-MTAB-8182, and are also 873 
available in raw and processed format on https://imaps.genialis.com/iclip. Additional 874 
datasets used in this study are listed in Supplementary Data Set 4. Source Data for Fig. 1c 875 
are available online. Other data are available upon request. 876 
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